Maria D. Maza-La
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
PERSEUS1: An Open-label, Investigator-initiated, Single arm, Phase 2 Trial Testing the Efficacy of Pembrolizumab in Patients with Metastatic Castration-resistant Prostate Cancer with Mismatch Repair Deficiency and Other Immune-sensitive Molecular Subtypes.
Journal: European urology oncology
Published: February 13, 2025
Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance.
Journal: Nature
Published: May 23, 2023
B7-H3 as a Therapeutic Target in Advanced Prostate Cancer.
Journal: European urology
Published: May 19, 2022
Immune Biomarkers in Metastatic Castration-resistant Prostate Cancer.
Journal: European urology oncology
Published: January 21, 2022
Characterizing CDK12-Mutated Prostate Cancers.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 24, 2020
Advanced Prostate Cancer with ATM Loss: PARP and ATR Inhibitors.
Journal: European urology
Published: May 22, 2020
Elucidating Durable Responses to Immune Checkpoint Inhibition.
Journal: European urology
Published: April 30, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026